Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 19, 2009
Extreme diabetic lipaemia associated with a novel lipoprotein lipase gene mutationAnna G McLean, Carolyn J Petersons, Amanda J Hooper, et al.
Therapeutic Drug Monitoring|November 6, 2019
Routine Therapeutic Drug Monitoring of Dabigatran: Experience at a Tertiary CenterPaul Ken Leong Chin, Richard McNeill, Hyun Kyoung Lee, et al.
British Journal of Clinical Pharmacology|February 16, 2020
The pharmacokinetics of metformin in patients receiving intermittent haemodialysisKlarissa A Sinnappah, Isabelle H S Kuan, Tilenka R J Thynne, et al.
The New Zealand Medical Journal|April 13, 2018
Metronidazole stewardship initiative at Christchurch hospitals-achievable with immediate benefitsSharon J Gardiner, Sarah Cl Metcalf, Paul Kl Chin, et al.
The Medical Journal of Australia|April 16, 2013
Mass or molar? Recommendations for reporting concentrations of therapeutic drugsGraham R D Jones, Stewart Bryant, Robert Fullinfaw, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2013
Free and total plasma cortisol measured by immunoassay and mass spectrometry following ACTH₁₋₂₄ stimulation in the assessment of pituitary patientsMorton G Burt, Brenda L Mangelsdorf, Anne Rogers, et al.
The Medical Journal of Australia|March 16, 2011
Detecting undiagnosed diabetes using glycated haemoglobin: an automated screening test in hospitalised patientsNyoli A Valentine, Tariq M Alhawassi, Greg W Roberts, et al.
European Journal of Clinical Pharmacology|September 30, 2016
A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysisDaniel Fb Wright, Matthew P Doogue, Murray L Barclay, et al.
Pharmacogenetics and Genomics|October 30, 2015
Warfarin resistance associated with genetic polymorphism of VKORC1: linking clinical response to molecular mechanism using computational modelingBenjamin C Lewis, Pramod C Nair, Subash S Heran, et al.
British Journal of Clinical Pharmacology|February 24, 2025
Investigation of a broad-spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient-drug interactionsBess M Kew, Matthew P Doogue, Richard McNeill, et al.
Pageof 4